Endocrinology News and Research

Latest Endocrinology News and Research

Genetic switch increases blood vessels in skeletal muscle of non-exercising mice

Many people suffer from a devastating condition known as critical limb ischemia (CLI) that can lead to muscle wasting and even amputation. The disease is linked to the blockage of blood flow to the skeletal muscle and current treatment options include rehabilitative exercise and surgical bypass of blood vessels. New preclinical research suggests there may be a way to restore blood supply in skeletal muscle without traditional intervention.

2 Mar 2011

Robotic surgery offers favourable outcomes in patients with kidney disease

Robotic surgery offers the same or better results than minimally invasive laparoscopic procedures for treating kidney disease, and can potentially help more patients because it is not as difficult for surgeons to learn, according to a new study led by Henry Ford Hospital specialists.

2 Mar 2011

Researchers discover three genes that contribute to abnormal growth

By working with Canadians of French ancestry who suffer a rare genetic disease, researchers have discovered how three genes contribute to abnormal growth, making a breakthrough that will improve our understanding of many disorders such as foetal and childhood growth retardation, abnormal development of body parts and cancer.

2 Mar 2011

Santaris licenses miR-33 from MGH to treat cardiovascular disorders

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.

1 Mar 2011

Dermatan sulfate holds potential as an additional biomarker for Sanfilippo disease

Sanfilippo disease is a rare disorder caused by the failure of enzymes to break down specific kinds of complex carbohydrates, resulting in their accumulation in cells and often severe physical and neurological problems - and sometimes early death.

1 Mar 2011

HP announces innovative drug research application for its inkjet technology

HP today announced an innovative drug research application for its inkjet technology that enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages.

1 Mar 2011

New study: Lifestyle intervention can help pregnant women control their weight

Excessive weight gain isn't healthy at any stage of life, but during pregnancy it can do lasting harm to the mother and baby alike. Now researchers at Brown University and The Miriam Hospital are encouraged by a new study describing an intervention that helped pregnant women control their weight.

1 Mar 2011

Omni Bio to expand Type 1 diabetes Phase I/II trial from 15 to 50 patients

Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.

28 Feb 2011

Sugary drinks and high blood pressure: Study establishes a link

A new study has found that drinking sugar-sweetened beverages such as soda pop and fruit drinks may increase blood pressure in adults. The results of the study came in Tuesday’s online issue of Hypertension, Journal of the American Heart Association.

28 Feb 2011

Cryo-Cell fiscal 2010 net income increases to $3.4 million

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks and an industry leader of innovative stem cell solutions, today announced results for its fiscal year 2010.

28 Feb 2011

Endo fourth quarter total revenues increase 31% to $511 million

Endo Pharmaceuticals today reported financial results for the fourth quarter 2010.

28 Feb 2011

Aeterna Zentaris receives $2.5M net sales milestone payment from Cowen Royalty

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it had received a net sales milestone of $2.5 million from Cowen Healthcare Royalty Partners, L.P..

28 Feb 2011

Researchers discover new mechanism of beta cell destruction not previously known

The death of insulin-producing beta cells in the pancreas is a core defect in diabetes. Scientists in Italy and Texas now have discovered a new way that these cells die - by toxic imbalance of a molecule secreted by other pancreatic cells.

28 Feb 2011

CTSI awards NYU one-year pilot grant to assess feasibility of hemoglobin A1C diabetes test

New York University's Clinical and Translational Science Institute has awarded an NYU nursing-dental research team a one-year pilot grant to assess the feasibility of using gingival crevicular blood from periodontal patients to gauge hemoglobin A1C -- a blood glucose measurement -- as a means of diagnosing diabetes and identifying pre-diabetes.

28 Feb 2011

AHRQ: $52.2 billion spent on prescription drugs for treatment of metabolic conditions during 2008

Insurers and consumers spent $52.2 billion on prescription drugs in 2008 for outpatient treatment of metabolic conditions such as diabetes and elevated cholesterol, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

28 Feb 2011

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease.

27 Feb 2011

Study: HT may affect symptom load and quality of life unrelated to hypothyroidism

Hashimoto's thyroiditis, an inflammatory disorder of the thyroid, is the most common cause of hypothyroidism, but a study has suggested that even when thyroid function is normal, HT may increase symptoms and decrease quality of life, as described in an article in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc.

27 Feb 2011

Research Roundup: Health costs at life's end; Assessing hospital quality; Surgeons' burnout; Per capita Medicaid spending

Annals of Internal Medicine: Determinants Of Medical Expenditures In The Last 6 Months Of Life - Identifying factors about patients in the final six months of life that affect the level of care needed "may reveal opportunities for patient-centered interventions to predict and to reduce medical costs," write the authors, while noting that the study had "a large proportion of unexplained variation."

25 Feb 2011

Takeda receives Japanese approval for additional indications for NESINA

Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited's applications for two additional indications for "NESINA®" (alogliptin), combination therapy with sulfonylurea and combination therapy with biguanide for type 2 diabetes, were approved by the Japanese Ministry of Health, Labour and Welfare.

25 Feb 2011

Viewpoints: WSJ on Medicare Advantage, Texas Gov. Perry on 'Fed inroads,' Med students' health policy ignorance

The White House has apparently decided that it won't enforce the unpopular parts of its health-care plan until after the 2012 election. The latest evidence is its decision not to slash Medicare Advantage, the program that Democrats hate because it lets seniors choose private insurance options. ... Would this be the same Medicare Advantage that candidate Barack Obama vowed to eliminate, saying in 2007 that "We shouldn't be rewarding the insurance industry for deceiving and defrauding our seniors"? (2/25).

25 Feb 2011

Endocrinology News and Research

Latest Endocrinology News and Research

Genetic switch increases blood vessels in skeletal muscle of non-exercising mice

Robotic surgery offers favourable outcomes in patients with kidney disease

Researchers discover three genes that contribute to abnormal growth

Santaris licenses miR-33 from MGH to treat cardiovascular disorders

Dermatan sulfate holds potential as an additional biomarker for Sanfilippo disease

HP announces innovative drug research application for its inkjet technology

New study: Lifestyle intervention can help pregnant women control their weight

Omni Bio to expand Type 1 diabetes Phase I/II trial from 15 to 50 patients

Sugary drinks and high blood pressure: Study establishes a link

Cryo-Cell fiscal 2010 net income increases to $3.4 million

Endo fourth quarter total revenues increase 31% to $511 million

Aeterna Zentaris receives $2.5M net sales milestone payment from Cowen Royalty

Researchers discover new mechanism of beta cell destruction not previously known

CTSI awards NYU one-year pilot grant to assess feasibility of hemoglobin A1C diabetes test

AHRQ: $52.2 billion spent on prescription drugs for treatment of metabolic conditions during 2008

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

Study: HT may affect symptom load and quality of life unrelated to hypothyroidism

Research Roundup: Health costs at life's end; Assessing hospital quality; Surgeons' burnout; Per capita Medicaid spending

Takeda receives Japanese approval for additional indications for NESINA

Viewpoints: WSJ on Medicare Advantage, Texas Gov. Perry on 'Fed inroads,' Med students' health policy ignorance

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Endocrinology News and Research

Latest Endocrinology News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in